Recombinant Citrobacter koseri Glycogen debranching enzyme (glgX), partial

Shipped with Ice Packs
In Stock

Description

Definition and Basic Properties

Recombinant Citrobacter koseri GlgX refers to a genetically modified, partially expressed form of the glycogen debranching enzyme derived from Citrobacter koseri (strain ATCC BAA-895). It is produced in yeast (Saccharomyces cerevisiae) and purified for experimental use .

Functional Role

GlgX works synergistically with glycogen phosphorylase to degrade glycogen:

  1. Phosphorylase cleaves α-1,4 linkages until reaching a branch point.

  2. GlgX hydrolyzes the remaining α-1,6 linkages, releasing linear chains for further degradation .

Expression and Purification4

  • Host Organism: Saccharomyces cerevisiae (yeast).

  • Tag: Undisclosed (determined during manufacturing).

  • Reconstitution: Soluble in deionized water with 50% glycerol for stability.

Experimental Uses

  • Enzymatic Assays: Study substrate specificity and kinetics using phosphorylase-limit dextrin.

  • Structural Biology: Comparative analysis with homologs (e.g., E. coli GlgX) .

  • Metabolic Studies: Investigate glycogen storage disorders (e.g., Glycogen Storage Disease Type III) .

Limitations

  • Partial Sequence: Lacks full-length protein context, potentially affecting activity or stability.

  • Species Specificity: Functional differences from human debranching enzymes limit translational relevance .

Comparative Analysis with Homologs

FeatureC. koseri GlgX (Partial)E. coli GlgXHuman GDE
Catalytic Activityα-1,6-glucosidaseα-1,6-glucosidaseTransferase + Glucosidase
StructurePartial (1-657 residues)Full-length (3 domains)Monomeric (175 kDa)
Host SystemYeastNative E. coliHuman cells
Role in GlycogenCatabolismCatabolismCatabolism

Research Gaps and Future Directions

  • Full-Length Expression: Requires characterization of the complete enzyme for functional validation.

  • Structural Studies: X-ray crystallography to resolve active-site mechanics.

  • Disease Modeling: Explore links to bacterial glycogen metabolism pathologies.

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins ship with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
glgX; CKO_04850; Glycogen debranching enzyme; EC 3.2.1.196; Limit dextrin alpha-1,6-maltotetraose-hydrolase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696)
Target Names
glgX
Uniprot No.

Target Background

Function
Removes maltotriose and maltotetraose chains attached by 1,6-alpha-linkage to the limit dextrin main chain, producing a debranched limit dextrin.
Database Links
Protein Families
Glycosyl hydrolase 13 family

Q&A

What is the primary function of GlgX in glycogen metabolism?

GlgX functions predominantly in glycogen catabolism by selectively debranching polysaccharide outer chains. Based on studies of GlgX in Escherichia coli, this enzyme specifically hydrolyzes α-1,6-glycosidic linkages of phosphorylase-limit dextrin containing only three or four glucose subunits produced by glycogen phosphorylase . This specific activity ensures that GlgX does not generate extensive futile cycles during glycogen synthesis, as it selectively targets chains that have been previously recessed by glycogen phosphorylase . In Citrobacter koseri, GlgX likely serves a similar function in glycogen degradation pathways, making it a key enzyme in bacterial energy metabolism.

How does the structure of C. koseri GlgX compare to the well-characterized E. coli GlgX?

While specific structural data for C. koseri GlgX is limited, extrapolation from the E. coli GlgX structure (determined at 2.25 Å resolution) suggests similar architectural features. The E. coli enzyme consists of three major domains with high structural similarity to the subunit of TreX, the oligomeric bifunctional glycogen debranching enzyme from Sulfolobus . Key structural features that likely exist in C. koseri GlgX include conserved residues that create a shorter, narrower substrate binding cleft compared to other debranching enzymes. Specifically, residues Leu270, Asp271, and Pro208 block the cleft in E. coli GlgX, yielding the characteristic shorter narrow cleft that explains its substrate specificity .

What determines the substrate specificity of glycogen debranching enzymes like GlgX?

The substrate specificity of GlgX toward short branched α-polyglucans (containing three or four glucose subunits) is primarily determined by its unique structural features. In E. coli GlgX, the substrate binding groove contains conserved residues that physically limit the space available for longer chains . Additionally, residues 207-213 form a distinctive helical conformation observed in both GlgX and TreX, which possibly distinguishes glycogen debranching enzymes from other related enzymes like isoamylases and pullulanases . This structural arrangement creates an environment that preferentially accommodates short branches, explaining why GlgX does not hydrolyze longer chains that are typically transferred by branching enzymes during glycogen synthesis.

What are the recommended expression systems for producing recombinant C. koseri GlgX?

Based on experiences with similar bacterial enzymes, the following expression systems are recommended for recombinant C. koseri GlgX production:

Expression SystemAdvantagesLimitationsOptimal Conditions
E. coli BL21(DE3)High yield, simple protocolPotential for inclusion bodiesIPTG induction at 0.1-0.5 mM, 16-25°C
E. coli RosettaBetter expression if rare codons presentHigher cost than standard strains0.1-0.2 mM IPTG, 18-20°C
E. coli Arctic ExpressImproved protein foldingSlower growth rateInduction at 10-12°C for 24-48 hours
Pichia pastorisPost-translational modificationsComplex optimization processMethanol induction, pH 6.0

The choice of expression system should be guided by the intended experimental use, required protein purity, and yield needs. For crystallography studies, E. coli systems with low-temperature induction often provide the best balance of yield and properly folded protein.

What purification strategies are most effective for recombinant GlgX enzymes?

A multi-step purification approach is typically necessary to obtain high-purity recombinant GlgX:

  • Initial capture: Affinity chromatography using His-tag or GST-fusion systems

  • Intermediate purification: Ion-exchange chromatography (typically anion exchange at pH 7.5-8.0)

  • Polishing: Size-exclusion chromatography

Critical parameters to monitor during purification include:

  • Buffer pH stability range (typically 6.5-8.0)

  • Salt concentration effects on solubility (typically 100-300 mM NaCl)

  • Addition of reducing agents (1-5 mM DTT or β-mercaptoethanol)

  • Temperature sensitivity (keep at 4°C throughout purification)

  • Potential requirement for glycerol (5-10%) to maintain stability

How can researchers accurately measure the enzymatic activity of recombinant C. koseri GlgX?

Several complementary assays can be employed to measure GlgX activity with varying levels of sensitivity and complexity:

Assay MethodPrincipleAdvantagesDetection LimitRequired Equipment
Iodine stainingDecrease in glycogen-iodine complex colorSimple, visual~50 μg/mL glycogenSpectrophotometer
Reducing sugar assay (DNS)Measures released glucose equivalentsQuantitative5-10 μg/mL glucoseSpectrophotometer
Coupled enzyme assayLinks glucose release to NADH productionReal-time kinetics1-5 μg/mL glucoseFluorometer or spectrophotometer
HPAEC-PADAnalysis of released oligosaccharidesHigh specificity0.1-1 μg/mLHPLC system with PAD

For initial activity screening, the iodine staining method provides a straightforward approach, while more detailed kinetic studies benefit from the coupled enzyme assay or HPAEC-PAD methods that offer greater sensitivity and specificity.

How can site-directed mutagenesis help elucidate the catalytic mechanism of C. koseri GlgX?

Site-directed mutagenesis represents a powerful approach to investigate the structure-function relationship in C. koseri GlgX. Based on the E. coli GlgX structural data, a systematic mutagenesis strategy might target:

  • Conserved residues in the substrate binding groove (especially Leu270, Asp271, and Pro208 equivalents)

  • Catalytic site residues involved in hydrolysis of α-1,6-glycosidic bonds

  • Residues forming the unique helical conformation (positions 207-213 in E. coli)

The experimental workflow should include:

  • Sequence alignment between C. koseri and E. coli GlgX to identify conserved residues

  • Design of primers for site-directed mutagenesis (typically alanine scanning)

  • Expression and purification of mutant proteins using identical conditions

  • Comparative enzymatic activity assays to determine effect of mutations

  • Substrate binding studies using isothermal titration calorimetry or surface plasmon resonance

This approach can reveal residues critical for substrate specificity, catalysis, and structural integrity.

What insights might comparative analysis of GlgX from different bacterial species provide?

Comparative analysis of GlgX across bacterial species can reveal evolutionary adaptations in glycogen metabolism:

SpeciesSubstrate SpecificityDomain OrganizationNotable Features
E. coliShort branches (3-4 glucose units)Three-domain monomerWell-characterized structure at 2.25 Å
C. koseriPredicted similar to E. coliLikely three-domain monomerGenomic context may differ from E. coli
Sulfolobus spp. (TreX)Broader substrate rangeSimilar to GlgX but oligomericBifunctional activity
Mycobacterium spp.VariableContains additional domainsAdaptation to different glycogen structure

Such comparisons can provide insights into:

  • Adaptation of glycogen metabolism across bacterial phylogeny

  • Evolution of substrate specificity

  • Relationship between enzyme structure and ecological niche

  • Species-specific regulatory mechanisms

How might recombinant C. koseri GlgX be utilized in structural biology studies?

Structural biology approaches for C. koseri GlgX characterization include:

These approaches can reveal:

  • Substrate binding mechanisms

  • Conformational changes during catalysis

  • Interactions with other enzymes in glycogen metabolism

  • Structural basis for substrate specificity

How does disruption of the glgX gene affect bacterial glycogen metabolism?

Studies in E. coli have shown that disruption of glgX leads to overproduction of glycogen containing short external chains . This phenotype results from the inability to debranch the outer chains during glycogen catabolism. The physiological consequences include:

  • Altered glycogen structure with increased branching density

  • Impaired mobilization of glycogen during nutrient limitation

  • Potential changes in stress resistance and adaptation

For C. koseri, a similar knockout approach would likely reveal species-specific aspects of glycogen metabolism and potentially highlight differences in metabolic adaptation compared to E. coli.

What is the relationship between C. koseri GlgX and bacterial pathogenesis or antibiotic resistance?

While the direct relationship between GlgX and pathogenesis remains to be fully elucidated, several connections can be hypothesized:

  • Glycogen metabolism contributes to bacterial survival during host infection and antibiotic stress

  • C. koseri strains have been found to carry various antibiotic resistance genes, including NDM-1

  • Metabolic adaptation through glycogen utilization may influence bacterial persistence

Research approaches to investigate these connections include:

  • Construction of glgX knockout C. koseri strains and evaluation in infection models

  • Transcriptomic analysis comparing wild-type and ΔglgX strains under various stress conditions

  • Investigation of glycogen metabolism during antibiotic exposure

  • Comparative genomic analysis of C. koseri clinical isolates to identify associations between glycogen metabolism genes and virulence/resistance factors

How can advanced genomic techniques enhance our understanding of C. koseri GlgX function?

Modern genomic approaches offer powerful tools for investigating GlgX function in C. koseri:

TechniqueApplicationExpected Insights
RNA-SeqTranscriptional profilingRegulation of glgX expression under different conditions
ChIP-SeqIdentification of transcription factor bindingRegulatory networks controlling glgX expression
CRISPR-Cas9Precise gene editingCreation of mutants with modified GlgX activity
Whole-genome sequencingComparative genomicsEvolutionary context of glgX across C. koseri strains

Integration of these approaches with biochemical characterization of the recombinant enzyme can provide a comprehensive understanding of GlgX function in C. koseri physiology and potentially reveal novel aspects of bacterial glycogen metabolism that differ from the E. coli model.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.